The third quarter of the financial year 2013 has generally been very weak. The common problem has been the demand slowdown and the pressure on margins due to inflation and competition. In most of the cases results have been below expectations. On the positive side, these challenging times are the best times to re-structure your … Continue reading Update on Quarterly Results
Welcome 2013!!! Hello Friends, we wish you and your family a very Happy & Prosperous New Year! 2012 has been a good year for our financial markets with the sensex gaining over 25% this year and beating all other asset classes. The best thing was that the mid caps (the area we focus on) outperformed … Continue reading The Best Ideas and stuff of 2012
Ajanta Pharma ranks among the Top 50 Pharmaceutical companies in India (IMS ORG MAT March 2012) with sales growing at 27% CAGR over FY06-12. Link to company financials – http://www.screener.in/company/?q=532331 Main Generic Brands: Ophthalmology (Olopat, Diflucor, Zaha, Unibrom, Nepaflam) Dermatology (Melacare, Pacroma, Salicia KT, Sunstop) Cardiology (Atorfit CV, Met XL, Rosufit) Anti-Malarials (Artefan – Artemether … Continue reading Ajanta Pharma and MPS Ltd
Wish you a very Happy and Prosperous Diwali friends. Tomorrow is the Muhurat Trading session from 3:45PM to 5PM and we would recommend all our readers to take part on this auspicious day. Our muhurat picks are (in no particular order): Atul Auto Balkrishna Industries GRP Mazda Polymedicure We are also studying Maithan Alloys and … Continue reading Happy Diwali: Muhurat Picks and Quarterly result updates
Last few days have been one of the most interesting and learning days for me. I travelled with a group of fellow investors and friends to Gujarat on company visit of few of the companies of our interest. We had some fantastic discussions day and night, and were able to do some very exciting ground … Continue reading Notes from company visits and AGMs
Q3 results have been generally good and most of our stock ideas have posted good performance. Here is a brief evaluation of their performance: 1. Balkrishna Ind: The company has yet again posted an excellent set of numbers and has surpassed the expectations. It is fantastic for a company with as large a turnover of … Continue reading Quarterly Results Update (Q3 FY12)
It is important to re-evaluate the portfolio and weed out non-performers, or the stocks in which the story is not developing as expected, or switch to new ideas which look cheaper or have more value than others. We have exited from couple of our ideas over last few days: 1. Jocil – Initially discussed @ … Continue reading Portfolio shuffling…
The results season is finally over and it has been a mixed bag. There haven’t been much instances of major outperformances but overall good topline growth is being witnessed while margins are under pressure. It’s a good time to buy into selected good companies as margins would come back over the long run. Results & … Continue reading Company Results Update…
Its results season again and a good time to monitor and shuffle your portfolio. Like we used to have exams earlier, similarly its result time for the stocks we invest into. In the mid/small cap space hardly 10-15% of the companies have come out with their numbers. Till now the results have generally been on … Continue reading Quarterly & Annual result update…
We had discussed about Sunflag Iron and provided an update earlier. At that time the company had been posting substantial improvement in operating margins and hence much better net profits and it seemed that the improved was because of the backward integration the company had been doing over last 2-3 years. But since last 2 … Continue reading Sunflag Iron – Update & Ideas